Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 10, 2011 - Issue 2
Submit an article Journal homepage
131
Views
11
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Safety evaluation of colesevelam therapy to achieve glycemic and lipid goals in type 2 diabetes

Nicholas Avitabile Tulane University School of Medicine, Section of Endocrinology, New Orleans, LA 70112, USA [email protected]
, MD,
Ajaz Banka Tulane University School of Medicine, Section of Endocrinology, New Orleans, LA 70112, USA [email protected]
&
Vivian A Fonseca Tulane University School of Medicine, Section of Endocrinology, New Orleans, LA 70112, USA [email protected]
Pages 305-310 | Published online: 19 Jan 2011

Bibliography

  • Steinmetz K. Colesevelam hydrochloride. Am J Health-Syst Pharm 2002;59:932-9
  • Product information. Welchol (Colesevelam hydrochloride) Parsippany, Daiichi Sankyo Inc., NJ; 2009
  • Brunetti L, Hermes-DeSantis ER. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus. Ann Pharmacother 2010;44:1196-206
  • Holmes-Farley SR, Manderville WH, Miller KL, Colesevelam hydrochloride: synthesis and testing of a novel polymer gel pharmaceutical. Polym Preprints 2000;41:735-6
  • Hanus M, Zhorov E. Bile acid salt binding with colesevelam is not affected after suspension in common beverages. J Pharm Sci 2006;95:2751-9
  • Davidson M, Hunninghake D, Olson T, Colesevelam HCl (WelcholTM), a new, potent, well tolerated, non systemic, lipid lowering agent. Paper presented at 12th international Symposium on Atherosclerosis. Stockholm, Sweden; 2000
  • Insull W, Toth P, Mullican W, Cholestagel, a novel, highly potent, polymeric bile acid sequestrant significantly lowers LDL cholesterol (Abstract). J Am Coll Cardiol 2000;35:258A
  • Braunlin W, Zhorov E, Smisek D, Invitro comparison of bile acid binding to colesevelam HCl and other bile acid sequestrants. Polym Preprints 2000;41:708-9
  • Goldberg RB, Fonseca VA, Truitt KE, Jones MR. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Arch Intern Med 2008;168:1531-40
  • Rosenstock J, Fonseca VA. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes. Endocr Pract 2010;16:629-40
  • Fonseca VA, Rosenstock J, Wang AC, Colesevelam HCl improves glycemic control and reducesLDLcholesterol inpatients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes Care 2008;31:1479-84
  • Goldfine AB, Fonseca VA, Jones MR, editors. Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes. Horm Metab Res 2010;42(1):23-30
  • Davidson MH, Dillon MA, Gordon B, Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 1999;159:1893-900

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.